NCI director places clinical trials among top priorities

Urologists can play important part in new research paradigm, Dr. vonEschenbach says

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria